Nohla Therapeutics
Latest round
- Series B
Last raised
- Jul 2018
Total raised
- $100M
Investors
- 10
About Nohla Therapeutics
Nohla Therapeutics Inc.Founded in 2015 and headquartered in Seattle, US, Nohla Therapeutics Inc. specializes in cell therapies that improve recovery for patients with blood-related disorders.Nohla Therapeutics specializes in innovative therapeutic solutions aimed at addressing unmet medical needs in the fields of hematology and oncology. The company's flagship product is an advanced cell therapy designed to enhance the recovery of patients undergoing stem cell transplants, particularly those affected by blood-related disorders. This therapy functions by leveraging proprietary techniques to improve the proliferation and efficacy of stem cells, thereby aiding in quicker and more effective patient recovery. Nohla Therapeutics primarily serves hospitals and specialized healthcare facilities, focusing on regions with significant healthcare infrastructure, including North America and parts of Europe.Nohla Therapeutics generates revenue through a structured model that includes partnerships with healthcare institutions and direct engagements with medical professionals. Transactions are typically structured around treatment protocols, with healthcare providers paying fees for each patient treatment cycle utilizing the company's therapeutic products. The pricing plans reflect the complex nature of cell therapies, considering factors such as treatment duration and the specific medical conditions being addressed.000 mn deal, to accelerate the development of new therapeutic products. The company aims to expand its market presence in Europe and Asia by 2025, targeting regions with unmet healthcare needs for advanced cell therapies.
Who invested in Nohla Therapeutics
10 investors across 3 rounds
See all investors in Nohla Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nohla Therapeutics
Who invested in Nohla Therapeutics?
Nohla Therapeutics has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nohla Therapeutics raised?
Nohla Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Nohla Therapeutics last raise money?
Nohla Therapeutics's most recent round on record is a Series B, in Jul 2018.
What does Nohla Therapeutics do?
Nohla Therapeutics is a biotechnology company.
Where is Nohla Therapeutics headquartered?
Nohla Therapeutics is headquartered in Seattle, US.
Which VCs invest in companies like Nohla Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nohla Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Nohla Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.